- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A multiomics disease progression signature of low-risk ccRCC ; volume:12 ; number:1 ; day:5 ; month:8 ; year:2022 ; pages:1-15 ; date:12.2022
Scientific reports ; 12, Heft 1 (5.8.2022), 1-15, 12.2022
- Creator
-
Strauss, Philipp
Rivedal, Mariell
Scherer, Andreas
Eikrem, Øystein
Nakken, Sigrid
Beisland, Christian
Bostad, Leif
Flatberg, Arnar
Skandalou, Eleni
Beisvåg, Vidar
Furriol, Jessica
Marti, Hans-Peter
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-17755-2
- URN
-
urn:nbn:de:101:1-2022102021475582859677
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Strauss, Philipp
- Rivedal, Mariell
- Scherer, Andreas
- Eikrem, Øystein
- Nakken, Sigrid
- Beisland, Christian
- Bostad, Leif
- Flatberg, Arnar
- Skandalou, Eleni
- Beisvåg, Vidar
- Furriol, Jessica
- Marti, Hans-Peter
- SpringerLink (Online service)
Other Objects (12)
Stemness related lncRNAs signature for the prognosis and tumor immune microenvironment of ccRCC patients
Multi-omics analysis of Prolyl 3-hydroxylase 1 as a prognostic biomarker for immune infiltration in ccRCC
Identification of key genes of the ccRCC subtype with poor prognosis
Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC
Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro
SCD5 regulation by VHL affects cell proliferation and lipid homeostasis in ccRCC
The Hippo pathway effector YAP inhibits HIF2 signaling and ccRCC tumor growth
ISG15 promotes tumor progression via IL6/JAK2/STAT3 signaling pathway in ccRCC
Identification of sex-specific tumour suppressor functions of KDM5C and KDM5D in ccRCC
Dissecting mechanisms of immune checkpoint therapy resistance in a mouse model of ccRcc
miR-4429 inhibits ccRCC proliferation, migration, and invasion by directly targeting CD274
Biomimetic Hydrogel‐Mediated Mechano‐Immunometabolic Therapy for Inhibition of ccRCC Recurrence After Surgery
Stemness related lncRNAs signature for the prognosis and tumor immune microenvironment of ccRCC patients
Multi-omics analysis of Prolyl 3-hydroxylase 1 as a prognostic biomarker for immune infiltration in ccRCC
Identification of key genes of the ccRCC subtype with poor prognosis
Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC
Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro
SCD5 regulation by VHL affects cell proliferation and lipid homeostasis in ccRCC
The Hippo pathway effector YAP inhibits HIF2 signaling and ccRCC tumor growth
ISG15 promotes tumor progression via IL6/JAK2/STAT3 signaling pathway in ccRCC
Identification of sex-specific tumour suppressor functions of KDM5C and KDM5D in ccRCC
Dissecting mechanisms of immune checkpoint therapy resistance in a mouse model of ccRcc
miR-4429 inhibits ccRCC proliferation, migration, and invasion by directly targeting CD274
Biomimetic Hydrogel‐Mediated Mechano‐Immunometabolic Therapy for Inhibition of ccRCC Recurrence After Surgery
Stemness related lncRNAs signature for the prognosis and tumor immune microenvironment of ccRCC patients
Multi-omics analysis of Prolyl 3-hydroxylase 1 as a prognostic biomarker for immune infiltration in ccRCC
Identification of key genes of the ccRCC subtype with poor prognosis
Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC
Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro
SCD5 regulation by VHL affects cell proliferation and lipid homeostasis in ccRCC
The Hippo pathway effector YAP inhibits HIF2 signaling and ccRCC tumor growth
ISG15 promotes tumor progression via IL6/JAK2/STAT3 signaling pathway in ccRCC
Identification of sex-specific tumour suppressor functions of KDM5C and KDM5D in ccRCC
Dissecting mechanisms of immune checkpoint therapy resistance in a mouse model of ccRcc
miR-4429 inhibits ccRCC proliferation, migration, and invasion by directly targeting CD274